All News

Global research spending soared in 2007, with Microsoft pulling into the lead. But don’t expect a repeat this year, warns Commissioner Potočnik.

Cash-rich pharma is dropping any pretence they are buying cash-strapped biotech for access to innovative technology. What it wants is products. Let’s hope it doesn’t suffocate the feedstock of innovation in the process.

Europe’s bid to lead the world in developing hydrogen and fuel cells risks failure because the planned investment is too little, the trade group Fuel Cell Europe heard.

Austrian MEP Paul Rübig received the European Patent Office’s 2008 award for Research & Innovation in recognition of his strong advocacy for small and medium-sized enterprises.

Two of the UK’s publicly funded nanotechtechnology promotion bodies have joined forces to speed the development of applications in regenerative medicine, diagnostics, imaging and drug discovery.

The first concrete result of work launched by the International Organization for Standardization in 2005 to develop standards for nanotechnologies has arrived.